A Case Report of Complete and Prolonged Response to Hormonal Therapy in Recurrent Metastatic Endometrial Cancer | Zendy

Nafiseh Faghih | Zendy; Maliheh Arab | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Case Report of Complete and Prolonged Response to Hormonal Therapy in Recurrent Metastatic Endometrial Cancer

Author(s) -

Nafiseh Faghih,

Maliheh Arab

Publication year - 2018

Publication title -

journal of obstetrics gynecology and cancer research

Language(s) - English

Resource type - Journals

eISSN - 2645-3843

pISSN - 2476-5848

DOI - 10.30699/jogcr.3.4.30

Subject(s) - hormonal therapy , endometrial cancer , medicine , oncology , cancer , metastatic breast cancer , hormone , hormone therapy , breast cancer

10.30699/jogcr.3.4.30 Background & Objective: Endometrial cancer is one of the most common gynecologic malignancies in developed countries. Survival rate in metastatic endometrial adenocarcinoma recurrence is reduced, and treatment in these patients is mostly palliative. One of the therapeutic options in the endometrial adenocarcinoma recurrence is hormone therapy. The expected response to the hormonal treatment is about 10-20%.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research